Category: In the News

Initiatives like the PINKCC challenge are really important to spur innovation around important challenges and establish strong, open benchmarks for the scientific community. But, even more importantly, they show a new generation of AI developers that AI can be used to address challenges that really make a difference to people’s lives. Dr Christopher Bridge –

Priority Session – Latest advances in imaging andtargeted radionuclide therapy Priority Session – Prof. Kevin Prise (Queen’s University Belfast, Ireland): New strategies for targeted alpha therapies in prostate cancer Priority Session – Dr. Timothée David (IRCM, France): In situ vaccine induced by intermediate dose of targeted radionuclide therapy Panacea Session – Cachexia and Cancer Panacea